While the CC and CT genotypes were in higher frequency in the 3 rd stage (40% and 50%) and in 4 th stage (36% and 54%) than controls (31% and 46%, respectively) with borderline significance.
← all excerpts
Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
1
—
—